The Hindu·3 min read·medium
Piramal Pharma Limited Announces Results for Q1 FY27
C
cuelive
✦AI Summary
Piramal Pharma Limited reported strong financial results for Q1 FY27, citing mid-to-high teens revenue growth across its business segments. The company plans to continue its momentum through disciplined brand investments and expansion in complex hospital generics.
MUMBAI, India , July 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30 th June 2026.
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in